N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autism.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4022412)

Published in Mol Autism on May 10, 2014

Authors

Keiko Iwata1, Hideo Matsuzaki2, Taro Tachibana3, Koji Ohno4, Saori Yoshimura3, Hironori Takamura5, Kohei Yamada5, Shinsuke Matsuzaki6, Kazuhiko Nakamura7, Kenji J Tsuchiya8, Kaori Matsumoto8, Masatsugu Tsujii9, Toshirou Sugiyama10, Taiichi Katayama6, Norio Mori11

Author Affiliations

1: Research Center for Child Mental Development, University of Fukui, Fukui, Japan ; Department of Development of Functional Brain Activities, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Fukui, Japan.
2: Research Center for Child Mental Development, University of Fukui, Fukui, Japan ; Department of Development of Functional Brain Activities, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Fukui, Japan ; Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan.
3: Department of Bioengineering, Graduate School of Engineering, Osaka City University, Osaka, Japan.
4: Department of Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
5: Department of Molecular Brain Science, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Osaka, Japan ; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Suita, Osaka, Japan.
6: Department of Molecular Brain Science, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Osaka, Japan.
7: Department of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
8: Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan.
9: Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan ; Faculty of Contemporary Sociology, Chukyo University, Toyota, Japan.
10: Department of Child and Adolescent Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
11: Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan ; Department of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Articles cited by this

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord (1994) 42.80

Mechanisms of intracellular protein transport. Nature (1994) 13.54

SNAREs--engines for membrane fusion. Nat Rev Mol Cell Biol (2006) 12.74

Structure and conformational changes in NSF and its membrane receptor complexes visualized by quick-freeze/deep-etch electron microscopy. Cell (1997) 5.72

Interaction of the N-ethylmaleimide-sensitive factor with AMPA receptors. Neuron (1998) 3.90

Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet (2006) 3.19

Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal (2003) 3.14

NSF binding to GluR2 regulates synaptic transmission. Neuron (1998) 2.92

SNAREs and NSF in targeted membrane fusion. Curr Opin Cell Biol (1997) 2.66

Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology (2001) 2.49

Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet (2005) 2.44

The AMPA receptor GluR2 C terminus can mediate a reversible, ATP-dependent interaction with NSF and alpha- and beta-SNAPs. Neuron (1998) 2.25

Autism spectrum disorders and epilepsy: moving towards a comprehensive approach to treatment. Brain Dev (2010) 2.21

Anticonvulsant effect of fluoxetine in humans. Neurology (1995) 2.20

The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr Res (2009) 2.01

NSF ATPase and alpha-/beta-SNAPs disassemble the AMPA receptor-PICK1 complex. Neuron (2002) 1.83

Serotonin and dopamine transporter binding in children with autism determined by SPECT. Dev Med Child Neurol (2008) 1.83

Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics (2006) 1.73

Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry (1997) 1.71

Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nat Biotechnol (2004) 1.63

The subcellular distribution of GABARAP and its ability to interact with NSF suggest a role for this protein in the intracellular transport of GABA(A) receptors. Mol Cell Neurosci (2001) 1.60

Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest (2008) 1.57

Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr (1961) 1.56

Regulating the conducting states of a mammalian serotonin transporter. Neuron (2003) 1.55

Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry (2010) 1.53

Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J Neurosci (2000) 1.43

Cellular functions of NSF: not just SNAPs and SNAREs. FEBS Lett (2007) 1.42

Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry (1996) 1.41

Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol (2000) 1.40

Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci U S A (2007) 1.38

Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry (2002) 1.36

Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry (1987) 1.35

Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet (1999) 1.31

GABAA receptor-associated protein traffics GABAA receptors to the plasma membrane in neurons. J Neurosci (2004) 1.28

Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J Neurochem (2002) 1.24

Binding of the beta2 adrenergic receptor to N-ethylmaleimide-sensitive factor regulates receptor recycling. J Biol Chem (2001) 1.23

Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter. J Biol Chem (2006) 1.23

Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol Psychiatry (2004) 1.21

Epilepsy and autism spectrum disorders: are there common developmental mechanisms? Brain Dev (2010) 1.20

Convulsing toward the pathophysiology of autism. Brain Dev (2008) 1.15

The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J Neurosci (2002) 1.15

Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation. Nat Neurosci (2010) 1.13

The autism-epilepsy connection. Epilepsia (2007) 1.12

Autistic spectrum disorder: evaluating a possible contributing or causal role of epilepsy. Epilepsia (2006) 1.11

A revised model for the oligomeric state of the N-ethylmaleimide-sensitive fusion protein, NSF. J Biol Chem (1998) 1.11

Requirements for the catalytic cycle of the N-ethylmaleimide-Sensitive Factor (NSF). Biochim Biophys Acta (2011) 1.08

Elevated blood serotonin in autistic probands and their first-degree relatives. J Autism Dev Disord (1989) 1.05

Dynamic regulation of GABA(A) receptors at synaptic sites. Brain Res Brain Res Rev (2002) 1.04

Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein. Eur J Neurosci (2006) 1.04

Expression of a high-affinity serotonin transporter in human lymphocytes. Int J Immunopharmacol (1994) 1.03

The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study. Neuropharmacology (2012) 1.02

Role of syntaxin 1A on serotonin transporter expression in developing thalamocortical neurons. Int J Dev Neurosci (2002) 0.99

Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2. J Biol Chem (2006) 0.99

GABAA receptor trafficking is regulated by protein kinase C(epsilon) and the N-ethylmaleimide-sensitive factor. J Neurosci (2010) 0.99

Visual Arrestin 1 acts as a modulator for N-ethylmaleimide-sensitive factor in the photoreceptor synapse. J Neurosci (2010) 0.99

Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. J Neuropsychiatry Clin Neurosci (1990) 0.96

The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure (2003) 0.95

Asymmetric accumulation of hippocampal 7S SNARE complexes occurs regardless of kindling paradigm. Epilepsy Res (2006) 0.95

Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism. Biol Psychiatry (2006) 0.95

Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology (2007) 0.95

Hyperserotonemia and amine metabolites in autistic and retarded children. Arch Gen Psychiatry (1977) 0.92

Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity. J Neurosci Methods (2007) 0.92

Interaction of the C-terminal region of the rat serotonin transporter with MacMARCKS modulates 5-HT uptake regulation by protein kinase C. Biochem Biophys Res Commun (2002) 0.90

Calcium/calmodulin-dependent kinase II regulates the interaction between the serotonin transporter and syntaxin 1A. Neuropharmacology (2008) 0.89

Genetic and expression analyses reveal elevated expression of syntaxin 1A ( STX1A) in high functioning autism. Int J Neuropsychopharmacol (2008) 0.89

Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology (2011) 0.88

Serotonin and measured intelligence. J Autism Dev Disord (1988) 0.86

Influence of ligand binding kinetics on functional inhibition of human recombinant serotonin and norepinephrine transporters. J Pharmacol Toxicol Methods (2009) 0.85

Partial regulation of serotonin transporter function by gamma-synuclein. Neurosci Lett (2009) 0.84

A single serine residue controls the cation dependence of substrate transport by the rat serotonin transporter. Proc Natl Acad Sci U S A (1997) 0.84

Lethal comatose mutation in Drosophila reveals possible role for NSF in neurogenesis. Neuroreport (2001) 0.83

Replication study of Japanese cohorts supports the role of STX1A in autism susceptibility. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.82

Serotonin uptake and release mechanisms in developing cultures of rat embryonic raphe neurons: age- and region-specific differences. Neuroscience (2000) 0.81

Characterization of rat rostral raphe primary cultures: multiplex quantification of serotonergic markers. J Neurosci Methods (2007) 0.80

Autoradiography reveals selective changes in serotonin binding in neocortex of patients with temporal lobe epilepsy. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.79

Vldlr overexpression causes hyperactivity in rats. Mol Autism (2012) 0.78

Hyperserotonemia and early infantile autism. N Engl J Med (1982) 0.77

Decrease of serotonin transporters in blood platelets after epileptic seizures. Neurochem Res (2005) 0.77

Epileptic seizures but not pseudoseizures are associated with decreased density of the serotonin transporter in blood platelet membranes. Neurochem Res (2008) 0.76